Berberine and Cinnamon in Management of Diabetes

National Nutrition and Food Technology Institute

Status: Completed

Conditions: Diabetes

Treatments: Other: Placebo (TDS); Dietary Supplement: Berberine+Cinnamon (TDS)

Study type: Interventional

Funder types: Other

Identifiers

NCT05570357

996401

Details and patient eligibility

About

In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.

Enrollment: 44 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 30-70 years
• Diagnosed type-2 diabetes mellitus (based on American Diabetes Association criteria)

Exclusion criteria

• Patients with an allergy to berberine /cinamon

  • Lactation, pregnancy
  • Patients with any malignancy
  • Patients with unrelated chronic illness
  • Patients with cardiac, liver or respiratory failure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

44 participants in 2 patient groups, including a placebo group

Intervention

Active Comparator group

Treatment:

Dietary Supplement: Berberine+Cinnamon (TDS)

Placebo

Placebo Comparator group

Treatment:

Other: Placebo (TDS)